Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Abacus Bidco Oy (which is the parent company of Accountor Software recently acquired by KKR) in the acquisition of certain subsidiaries and assets of 24SevenOffice Group AB (“24SevenOffice”)
Mandate

Vinge advises Abacus Bidco Oy (which is the parent company of Accountor Software recently acquired by KKR) in the acquisition of certain subsidiaries and assets of 24SevenOffice Group AB (“24SevenOffice”)  

November 13, 2024 M&A Capital Markets and Public M&A

24SevenOffice is a listed company (First North Stockholm) that provides modular software for accounting, ERP and business services that automate processes using AI.

The transaction primarily relates to ERP-related subsidiaries and assets, including 24SevenOffice Norway AS, 24SevenOffice Scandinavian Systems and 24SevenOffice Sweden AB. Following completion of the transaction, the acquired assets and subsidiaries will be integrated with Accountor Software.

The purchase price for the ERP-related subsidiaries and assets corresponds to an enterprise value of approximately SEK 2.4 billion.

The transaction is subject to approval by the shareholders of 24SevenOffice and regulatory approval.

Vinge's team consisted primarily of Christina Kokko, Matthias Pannier, Gustav Persson and Ian Linde (M&A), Sofie Bjärtun and Joel Magnusson (Capital Markets and Public M&A), Johan Gavelin (IP), Alice Göransson (Employment), Madelene Andersson (Real Estate), Daniel Wendelsson (FDI), Christoffer Nordin and Katja Häglund (Commercial Agreements), Nicklas Thorgerzon (IT and GDPR), Calle Tengwall Pagels and William Carlberg Johansson (Banking and Finance), Caroline Krassén (Financial Services), Caroline Löv and Filippa Bergkvist (Transaction Support).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

 Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

 Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025